P165 | GAIN/AMPLIFICATION OF 1Q IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMAB-BASED REGIMENS: A SINGLE-CENTER RETROSPECTIVE STUDY
Gain/amplification of chromosome arm 1q (+1q) is one of the most frequent cytogenetic abnormalities (CAs) in multiple myeloma (MM), and it is now widely acknowledged as a poor prognostic marker, included in all modern staging systems. Anti-CD38 monoclonal antibodies (moAbs), particularly daratumuma...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Ferrata Storti Foundation
2025-09-01
|
| Sraith: | Haematologica |
| Rochtain ar líne: | https://haematologica.org/article/view/12362 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|